Loperamide Hydrochloride
- Product NDC
- 70518-3400
- 11-digit product format
- 705183400
- Labeler code
- 70518
- Product ID
- 70518-3400_eedb03c8-3689-5824-e053-2995a90ac55e
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- loperamide hydrochloride
- Dosage form
- CAPSULE
- Route
- ORAL
- Labeler
- REMEDYREPACK INC.
- Application
- ANDA215579
- Marketing category
- ANDA
- Marketing start
- 2022-04-04
- Marketing end
- 0000-00-00
- Substance
- LOPERAMIDE HYDROCHLORIDE
- Active strength
- 2 mg/1
- Pharmacologic classes
- Opioid Agonist [EPC], Opioid Agonists [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2023-12-31
- Current FDA listing
- Historical FDA.report record
NDC auxiliary status#
These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.
| Dataset | Scope | Product NDC | Package NDC | Code | Status | Reporting period | Source date |
|---|---|---|---|---|---|---|---|
| excluded product | product | 70518-3400 | D | Discontinued by firm | 2026-08-07 | ||
| excluded package | package | 70518-3400 | 70518-3400-0 | D | Discontinued by firm | 2026-08-07 | |
| excluded package | package | 70518-3400 | 70518-3400-1 | D | Discontinued by firm | 2026-08-07 | |
| excluded package | package | 70518-3400 | 70518-3400-2 | D | Discontinued by firm | 2026-08-07 | |
| excluded package | package | 70518-3400 | 70518-3400-3 | D | Discontinued by firm | 2026-08-07 | |
| excluded package | package | 70518-3400 | 70518-3400-4 | D | Discontinued by firm | 2026-08-07 |
Observed NDC auxiliary status history#
This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
| Captured / source date | Dataset | Scope | Product NDC | Package NDC | Code | Status | Reporting period | Archive | Snapshot | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025-12-14 17:58 UTC · source 2025-12-05 | excluded package | package | 70518-3400 | 70518-3400-0 | D | Discontinued by firm | excluded / ndc_excluded.zip | d630ba8d3edf… | 732f749b63fb… | |
| 2025-08-27 00:01 UTC · source 2025-08-26 | excluded package | package | 70518-3400 | 70518-3400-0 | D | Discontinued by firm | excluded / ndc_excluded.zip | f5e01cc5f278… | a2eaf40c39c3… |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A215579-001 | LOPERAMIDE HYDROCHLORIDE | LOPERAMIDE HYDROCHLORIDE | 2MG | CAPSULE / ORAL | AB | 2021-10-22 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| A215579-001 | AB |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-02-19 14:30 UTC | 2026-02 | A215579-001 | LOPERAMIDE HYDROCHLORIDE | 2MG | CAPSULE / ORAL | AB | 2021-10-22 | 011fe1cb6892… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A215579-001 | LOPERAMIDE HYDROCHLORIDE | 2MG | CAPSULE / ORAL | AB | 2021-10-22 | 31067a03dcf5… | |
| 2025-08-23 18:47 UTC | 2025-08 | A215579-001 | LOPERAMIDE HYDROCHLORIDE | 2MG | CAPSULE / ORAL | AB | 2021-10-22 | 6a471c1ec25d… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A215579-001 | LOPERAMIDE HYDROCHLORIDE | 2MG | CAPSULE / ORAL | AB | 2021-10-22 | fd3edfee7708… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A215579-001 | LOPERAMIDE HYDROCHLORIDE | 2MG | CAPSULE / ORAL | AB | 2021-10-22 | b8a1b40f171c… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A215579-001 | LOPERAMIDE HYDROCHLORIDE | 2MG | CAPSULE / ORAL | AB | 2021-10-22 | 03ed91905a0d… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A215579-001 | LOPERAMIDE HYDROCHLORIDE | 2MG | CAPSULE / ORAL | AB | 2021-10-22 | 2680178bc6a6… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A215579-001 | LOPERAMIDE HYDROCHLORIDE | 2MG | CAPSULE / ORAL | AB | 2021-10-22 | 5bbf6a4d5a75… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A215579-001 | LOPERAMIDE HYDROCHLORIDE | 2MG | CAPSULE / ORAL | AB | 2021-10-22 | d8e5a09893c0… | |
| 2024-10-29 15:01 UTC | 2024-10 | A215579-001 | LOPERAMIDE HYDROCHLORIDE | 2MG | CAPSULE / ORAL | AB | 2021-10-22 | d06236e962d9… | |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A215579-001 | LOPERAMIDE HYDROCHLORIDE | 2MG | CAPSULE / ORAL | AB | 2021-10-22 | 79d66fd596c7… | |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A215579-001 | LOPERAMIDE HYDROCHLORIDE | 2MG | CAPSULE / ORAL | AB | 2021-10-22 | 301d65b070ca… | |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A215579-001 | LOPERAMIDE HYDROCHLORIDE | 2MG | CAPSULE / ORAL | AB | 2021-10-22 | 1e350fbaab3a… | |
| 2024-05-31 18:47 UTC | 2024-05 | A215579-001 | LOPERAMIDE HYDROCHLORIDE | 2MG | CAPSULE / ORAL | AB | 2021-10-22 | 8072bd15b7f6… | |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | A215579-001 | LOPERAMIDE HYDROCHLORIDE | 2MG | CAPSULE / ORAL | AB | 2021-10-22 | 5c6f7cd8ea54… | |
| 2022-04-08 23:34 UTC | 2022-04 | A215579-001 | LOPERAMIDE HYDROCHLORIDE | 2MG | CAPSULE / ORAL | AB | 2021-10-22 | 5d02ea3f76ae… | |
| 2022-04-04 05:41 UTC | 2022-04 | A215579-001 | LOPERAMIDE HYDROCHLORIDE | 2MG | CAPSULE / ORAL | AB | 2021-10-22 | 4b0b4de00fa7… | |
| 2022-03-09 01:35 UTC | 2022-03 | A215579-001 | LOPERAMIDE HYDROCHLORIDE | 2MG | CAPSULE / ORAL | AB | 2021-10-22 | bb7c543d1eb4… | |
| 2021-12-28 21:50 UTC | 2021-12 | A215579-001 | LOPERAMIDE HYDROCHLORIDE | 2MG | CAPSULE / ORAL | AB | 2021-10-22 | 782e0a99824c… | |
| 2024-03-16 18:09 UTC · 4 captures of this ZIP | 2024-03 | A215579-001 | LOPERAMIDE HYDROCHLORIDE | 2MG | CAPSULE / ORAL | AB | 2021-10-22 | 6a51e52b5d6a… | |
| 2024-02-18 07:12 UTC | 2024-02 | A215579-001 | LOPERAMIDE HYDROCHLORIDE | 2MG | CAPSULE / ORAL | AB | 2021-10-22 | 1c564ffb4f44… | |
| 2023-12-20 04:57 UTC | 2023-12 | A215579-001 | LOPERAMIDE HYDROCHLORIDE | 2MG | CAPSULE / ORAL | AB | 2021-10-22 | ea1830bbd6c7… | |
| 2023-11-28 05:40 UTC · 2 captures of this ZIP | 2023-11 | A215579-001 | LOPERAMIDE HYDROCHLORIDE | 2MG | CAPSULE / ORAL | AB | 2021-10-22 | a72a2bbeb626… | |
| 2023-10-25 00:34 UTC · 2 captures of this ZIP | 2023-10 | A215579-001 | LOPERAMIDE HYDROCHLORIDE | 2MG | CAPSULE / ORAL | AB | 2021-10-22 | 9b2671bbb829… | |
| 2023-07-15 15:27 UTC · 2 captures of this ZIP | 2023-07 | A215579-001 | LOPERAMIDE HYDROCHLORIDE | 2MG | CAPSULE / ORAL | AB | 2021-10-22 | a67488948f0b… | |
| 2023-06-13 01:57 UTC · 3 captures of this ZIP | 2023-06 | A215579-001 | LOPERAMIDE HYDROCHLORIDE | 2MG | CAPSULE / ORAL | AB | 2021-10-22 | 3f0d92c62455… | |
| 2023-05-13 08:27 UTC | 2023-05 | A215579-001 | LOPERAMIDE HYDROCHLORIDE | 2MG | CAPSULE / ORAL | AB | 2021-10-22 | 053a50430f4f… | |
| 2023-01-26 05:58 UTC | 2023-01 | A215579-001 | LOPERAMIDE HYDROCHLORIDE | 2MG | CAPSULE / ORAL | AB | 2021-10-22 | 3bdfa0b2c4d7… | |
| 2022-11-12 20:34 UTC · 5 captures of this ZIP | 2022-11 | A215579-001 | LOPERAMIDE HYDROCHLORIDE | 2MG | CAPSULE / ORAL | AB | 2021-10-22 | 3a93d1ddd44b… | |
| 2022-10-28 04:53 UTC | 2022-10 | A215579-001 | LOPERAMIDE HYDROCHLORIDE | 2MG | CAPSULE / ORAL | AB | 2021-10-22 | f41ea6bd6efb… | |
| 2022-09-29 23:25 UTC | 2022-09 | A215579-001 | LOPERAMIDE HYDROCHLORIDE | 2MG | CAPSULE / ORAL | AB | 2021-10-22 | e64feba35796… | |
| 2022-07-09 03:26 UTC · 3 captures of this ZIP | 2022-07 | A215579-001 | LOPERAMIDE HYDROCHLORIDE | 2MG | CAPSULE / ORAL | AB | 2021-10-22 | cb3db0bc1861… | |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A215579-001 | LOPERAMIDE HYDROCHLORIDE | 2MG | CAPSULE / ORAL | AB | 2021-10-22 | a50c72e98297… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-02-19 14:30 UTC | 2026-02 | A215579-001 | AB | 1 | 011fe1cb6892… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A215579-001 | AB | 1 | 31067a03dcf5… |
| 2025-08-23 18:47 UTC | 2025-08 | A215579-001 | AB | 1 | 6a471c1ec25d… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A215579-001 | AB | 1 | fd3edfee7708… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A215579-001 | AB | 1 | b8a1b40f171c… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A215579-001 | AB | 1 | 03ed91905a0d… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A215579-001 | AB | 1 | 2680178bc6a6… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A215579-001 | AB | 1 | 5bbf6a4d5a75… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A215579-001 | AB | 1 | d8e5a09893c0… |
| 2024-10-29 15:01 UTC | 2024-10 | A215579-001 | AB | 1 | d06236e962d9… |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A215579-001 | AB | 1 | 79d66fd596c7… |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A215579-001 | AB | 1 | 301d65b070ca… |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A215579-001 | AB | 1 | 1e350fbaab3a… |
| 2024-05-31 18:47 UTC | 2024-05 | A215579-001 | AB | 1 | 8072bd15b7f6… |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | A215579-001 | AB | 1 | 5c6f7cd8ea54… |
| 2022-04-08 23:34 UTC | 2022-04 | A215579-001 | AB | 1 | 5d02ea3f76ae… |
| 2022-04-04 05:41 UTC | 2022-04 | A215579-001 | AB | 1 | 4b0b4de00fa7… |
| 2022-03-09 01:35 UTC | 2022-03 | A215579-001 | AB | 1 | bb7c543d1eb4… |
| 2021-12-28 21:50 UTC | 2021-12 | A215579-001 | AB | 1 | 782e0a99824c… |
| 2024-03-16 18:09 UTC · 4 captures of this ZIP | 2024-03 | A215579-001 | AB | 1 | 6a51e52b5d6a… |
| 2024-02-18 07:12 UTC | 2024-02 | A215579-001 | AB | 1 | 1c564ffb4f44… |
| 2023-12-20 04:57 UTC | 2023-12 | A215579-001 | AB | 1 | ea1830bbd6c7… |
| 2023-11-28 05:40 UTC · 2 captures of this ZIP | 2023-11 | A215579-001 | AB | 1 | a72a2bbeb626… |
| 2023-10-25 00:34 UTC · 2 captures of this ZIP | 2023-10 | A215579-001 | AB | 1 | 9b2671bbb829… |
| 2023-07-15 15:27 UTC · 2 captures of this ZIP | 2023-07 | A215579-001 | AB | 1 | a67488948f0b… |
| 2023-06-13 01:57 UTC · 3 captures of this ZIP | 2023-06 | A215579-001 | AB | 1 | 3f0d92c62455… |
| 2023-05-13 08:27 UTC | 2023-05 | A215579-001 | AB | 1 | 053a50430f4f… |
| 2023-01-26 05:58 UTC | 2023-01 | A215579-001 | AB | 1 | 3bdfa0b2c4d7… |
| 2022-11-12 20:34 UTC · 5 captures of this ZIP | 2022-11 | A215579-001 | AB | 1 | 3a93d1ddd44b… |
| 2022-10-28 04:53 UTC | 2022-10 | A215579-001 | AB | 1 | f41ea6bd6efb… |
| 2022-09-29 23:25 UTC | 2022-09 | A215579-001 | AB | 1 | e64feba35796… |
| 2022-07-09 03:26 UTC · 3 captures of this ZIP | 2022-07 | A215579-001 | AB | 1 | cb3db0bc1861… |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A215579-001 | AB | 1 | a50c72e98297… |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 70518-3400 | LOPERAMIDE HYDROCHLORIDE CAPSULE [REMEDYREPACK INC.] | 6 | Legacy NDC | 20240927_e3d3f75a-272b-4c85-804f-b04544ae90e7.zip |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Loperamide Hydrochloride | LOPERAMIDE HYDROCHLORIDE | AvPAK | f8992723-dd9a-bcf6-e053-6294a90aa65c | 2025-01-09 | Boxed warning, Warnings, Adverse reactions | 215579 ANDA215579 |
| Loperamide Hydrochloride | LOPERAMIDE HYDROCHLORIDE | NuCare Pharmaceuticals,Inc. | df4e7076-fd25-aeb8-e053-2995a90a2aa0 | 2024-05-07 | Boxed warning, Warnings, Adverse reactions | 215579 ANDA215579 |
| Loperamide Hydrochloride | LOPERAMIDE HYDROCHLORIDE | Bryant Ranch Prepack | 691c5dd6-b85d-482b-a8c1-8c4b48b48dc9 | 2024-04-03 | Boxed warning, Warnings, Adverse reactions | 215579 ANDA215579 |
| Loperamide Hydrochloride | LOPERAMIDE HYDROCHLORIDE | Bionpharma Inc. | 6e60cb25-6af9-4f17-b740-a5e7b5bb2a09 | 2023-12-27 | Boxed warning, Warnings, Adverse reactions | 215579 ANDA215579 |
Packages#
| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|---|
| 70518-3400-0 | 70518340000 | 30 CAPSULE in 1 BLISTER PACK (70518-3400-0) | 30 capsule | 2022-04-04 | 0000-00-00 | No | No | Current |
| 70518-3400-1 | 70518340001 | 10 CAPSULE in 1 BLISTER PACK (70518-3400-1) | 10 capsule | 2022-05-02 | 0000-00-00 | No | No | Current |